Oxitope Pharma
Latest round
- Seed
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 1
About Oxitope Pharma
V. is a biopharmaceutical start-up that engages in the discovery and development of medicines for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress.V. merged with Arxx Therapeutics AS, a portfolio company of Rasmussengruppen AS, Investinor, altitude Capital Management, Veen Eiendom AS, P53, Sarsia Management, Trond Mohn Stiftelsen, MP Pensjon, Asteroidebakken AS, and Andenes Investments, to form Calluna Pharma. The company focuses on developing drugs to treat inflammatory and cardiovascular disorders caused by oxidised phospholipids. The firm's strategy is based on avoiding, slowing, or even reversing acute and chronic diseases. Oxitope specializes in the identification and development of oxidised phospholipid (OxPL) antibodies, with a focus on their therapeutic potential across a wide range of disorders involving inflammation and cellular signalling networks. Oxidized phospholipids (OxPLs) are complex molecules produced during normal or pathological processes. The company's first development candidate focuses on acute indications, particularly cardiovascular disease (CVD). Oxitope Pharma has identified OxPLs in MI-IRI and their association with elevated cardiovascular disease risk. The company is also working on antibodies that target oxidation-specific epitopes (OSEs) on OxPLs.
Who invested in Oxitope Pharma
1 investor across 1 round
See all investors in Oxitope Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 16, 2021
Amount
Undisclosed
Investors
Questions about Oxitope Pharma
Who invested in Oxitope Pharma?
Oxitope Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oxitope Pharma raised?
Oxitope Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oxitope Pharma last raise money?
Oxitope Pharma's most recent round on record is a Seed, in Sep 2021.
What does Oxitope Pharma do?
Oxitope Pharma is a biotechnology company.
Where is Oxitope Pharma headquartered?
Oxitope Pharma is headquartered in Naarden, Netherlands.
Which VCs invest in companies like Oxitope Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Oxitope Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Oxitope Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.